Physician profile
Brett C Branson
NPI 1598743023
$3,613.15
in general payments reported to CMS, 2019-2025
32 companies · $601 in 2025
The $601 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $466 · 2020: $207 · 2021: $212 · 2022: $860 · 2023: $694 · 2024: $572 · 2025: $601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,754 · Education: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,754.07 |
| Education | $113.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $500.56 | 2022-2024 | Ova1 |
| Abbvie INC. | $477.14 | 2019-2024 | Lo Loestrin Fe, Orilissa, Liletta |
| Astellas Pharma US INC | $425.76 | 2022-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $240.40 | 2020-2025 | Slynd |
| Organon LLC | $210.62 | 2021-2025 | Nexplanon, Jada System |
| Mayne Pharma Commercial LLC | $180.34 | 2022-2025 | |
| Millicent US INC | $137.71 | 2022-2025 | Intrarosa, Femring, Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $132.84 | 2022-2025 | |
| Avanos Medical | $121.12 | 2019 | |
| Biogen, INC. | $107.88 | 2024-2025 | Zurzuvae |
| Shield Therapeutics INC | $98.54 | 2023-2025 | Accrufer |
| Therapeuticsmd, INC. | $98.27 | 2020-2022 | |
| Exact Sciences Corporation | $90.94 | 2023-2024 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $84.28 | 2019-2025 | Aptima |
| Daiichi Sankyo INC. | $83.73 | 2019-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $77.37 | 2019-2022 | |
| Coopersurgical, INC. | $68.80 | 2019-2025 | Paragard T 380a, Sos |
| Myriad Women'S Health, INC. | $66.78 | 2023 | Myrisk |
| Merck Sharp & Dohme LLC | $57.02 | 2019-2020 | |
| Agile Therapeutics, INC. | $55.83 | 2021-2022 | |
| Pfizer INC. | $55.43 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $43.85 | 2025 | Myfembree |
| Allergan, INC. | $36.83 | 2019 | |
| Vertical Pharmaceuticals, LLC | $26.30 | 2019 | |
| Duchesnay USA Incorporated | $25.97 | 2019 | |
| Myovant Sciences INC. | $25.97 | 2022 | |
| Gynesonics, INC. | $22.45 | 2022 | |
| Evofem Biosciences, INC. | $12.94 | 2020 | |
| Conmed Corporation | $12.56 | 2019 | |
| Amgen INC. | $12.52 | 2020 | |
| Lupin INC. | $11.24 | 2019 | |
| Avion Pharmaceuticals | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Branson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.